These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7386257)

  • 1. Radioimmunoassay of serum thromboxane B2: a simple method of assessing pharmacologic effects on platelet function.
    Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
    Adv Prostaglandin Thromboxane Res; 1980; 6():187-91. PubMed ID: 7386257
    [No Abstract]   [Full Text] [Related]  

  • 2. Methodological assessment and applications of a radioimmunoassay for thromboxane (TxB2) to measurement of TxB2 release by platelets.
    Giannessi D; De Caterina R; Gazzetti P; Bernini W; Masini S; Zucchelli GC
    J Nucl Med Allied Sci; 1982; 26(1):25-33. PubMed ID: 7108634
    [No Abstract]   [Full Text] [Related]  

  • 3. A radioimmunoassay for thromboxane B2.
    Fitzpatrick FA; Gorman RR; Mc Guire JC; Kelly RC; Wynalda MA; Sun FF
    Anal Biochem; 1977 Sep; 82(1):1-7. PubMed ID: 907115
    [No Abstract]   [Full Text] [Related]  

  • 4. Thromboxane-B2 generation during ex-vivo platelet aggregation.
    De Caterina R; Giannessi D; Gazzetti P; Bernini W
    J Nucl Med Allied Sci; 1984; 28(3):185-96. PubMed ID: 6530623
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical effects of indomethacin and trifluoperazine on Ca2+ ionophore A23187-induced human platelet aggregation, thromboxane B2 production, and dense granule release.
    Krishnamurthi S; Westwick J; Kakkar VV
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():435-40. PubMed ID: 6221559
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement of thromboxane B2 in human plasma or serum by radioimmunoassay.
    Viinikka L; Ylikorkala O
    Prostaglandins; 1980 Oct; 20(4):759-66. PubMed ID: 7465865
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of platelet function and thromboxane B2 levels across the human myocardial vascular bed.
    Mehta J; Mehta P
    Acta Med Scand Suppl; 1981; 651():111-21. PubMed ID: 6948499
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension.
    Gensini GF; Rostagno C; Pezza A; Fanara F; Castellani S; Prisco D; Rogasi PG; Boddi M; Neri Serneri GG
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():257-62. PubMed ID: 3159209
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of cyclosporine on human platelet aggregation and thromboxane release.
    Jorkasky DK; Fisher CA; Stahl RF; Addonizio VP; Glickman JD
    Transplant Proc; 1989 Feb; 21(1 Pt 1):948-9. PubMed ID: 2705264
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose- and time-dependent antiplatelet effects of aspirin.
    Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
    Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombocyte function and the prostacyclin-thromboxane system in patients with acute myocardial infarct].
    Aliavi AL
    Vrach Delo; 1988 Mar; (3):42-4. PubMed ID: 3293319
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence that extracellular calcium ions inhibit thromboxane B2 biosynthesis by human platelets.
    Best LC; Jones PB; Russell RG
    Biochem Biophys Res Commun; 1979 Oct; 90(4):1179-85. PubMed ID: 117802
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimation of thromboxane B2 in the clotting human whole blood by gas chromatography.
    Block HU; Sziegoleit W; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S385-8. PubMed ID: 6517904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme immunoassay of thromboxane B2.
    Hayashi Y; Ueda N; Yokota K; Kawamura S; Ogushi F; Yamamoto Y; Yamamoto S; Nakamura K; Yamashita K; Miyazaki H; Kato K; Terao S
    Biochim Biophys Acta; 1983 Feb; 750(2):322-9. PubMed ID: 6407530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet thromboxanes and serum-cholesterol.
    Tremoli E; Folco G; Agradi E; Galli C
    Lancet; 1979 Jan; 1(8107):107-8. PubMed ID: 84115
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypercoagulability and cerebral infarction].
    Matsuda T
    No To Shinkei; 1986 Apr; 38(4):317-27. PubMed ID: 3013261
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzyme immunoassay of thromboxane B2 and 6-keto-prostaglandin F1 alpha as a substitute for radioimmunoassay.
    Yamamoto S; Hayashi Y; Yano T; Ueda N; Kawamura S; Ogushi F; Nakamura K
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():181-4. PubMed ID: 6221523
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay for plasma thromboxane B2.
    McCann DS; Tokarsky J; Sorkin RP
    Clin Chem; 1981 Aug; 27(8):1417-20. PubMed ID: 7273401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.